Neurocrine Biosciences (NBIX) Non Operating Investment Income (2010 - 2026)
Neurocrine Biosciences' Non Operating Investment Income was $28.6 million in Q1 2026.
Analysis
Neurocrine Biosciences (NBIX) Non Operating Investment Income (2010 - 2026) Analysis & Trends
For FY2013, Non Operating Investment Income at Neurocrine Biosciences came in at $2,000, down 93.8% from FY2012.
- Non Operating Investment Income has now declined for three consecutive years, with a four-year compound annual growth rate of -77.9% (FY2009 to FY2013).
- In earlier years, Non Operating Investment Income was $32,000 in FY2012 (-86.8%), $242,000 in FY2011 (-78.7%), $1.13 million in FY2010 (+34.8%) and $841,000 in FY2009.
- The Q1 2026 figure marks the highest quarterly Non Operating Investment Income in data going back to Q2 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 28.60 Mn |
| Mar 31, 2015 | 9,000.00 |
| Dec 31, 2014 | 4,000.00 |
| Sep 30, 2014 | 1,000.00 |
| Jun 30, 2014 | 5,000.00 |
| Mar 31, 2014 | -10,000.00 |
| Dec 31, 2013 | -36,000.00 |
| Sep 30, 2013 | 6,000.00 |
| Jun 30, 2013 | 19,000.00 |
| Mar 31, 2013 | 13,000.00 |
| Dec 31, 2012 | 7,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Dec 31, 2011 | 58,000.00 |
| Sep 30, 2011 | 86,000.00 |
| Jun 30, 2011 | 18,000.00 |
| Mar 31, 2011 | 80,000.00 |
| Dec 31, 2010 | 932,000.00 |
| Sep 30, 2010 | 34,000.00 |
| Jun 30, 2010 | 53,000.00 |
API Access
Neurocrine Biosciences Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NBIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();